Previous Article | Next Article 
Journal of Clinical Microbiology, April 2007, p. 1133-1139, Vol. 45, No. 4
0095-1137/07/$08.00+0 doi:10.1128/JCM.00042-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Virulence Gene- and Pandemic Group-Specific Marker Profiling of Clinical Vibrio parahaemolyticus Isolates
Carolyn E. Meador,1
Michele M. Parsons,2
Cheryl A. Bopp,2
Peter Gerner-Smidt,2
John A. Painter,2 and
Gary J. Vora3*
Nova Research, Inc., Alexandria, Virginia,1
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia,2
Center for Bio/Molecular Science & Engineering, Naval Research Laboratory, Washington, DC3
Received 5 January 2007/
Returned for modification 5 February 2007/
Accepted 8 February 2007
Vibrio parahaemolyticus is a halophilic bacterium capable of causing food- and waterborne gastroenteritis, wound infections, and septicemia in humans. The organism has recently received increasing attention, as the emergence of a new clone, V. parahaemolyticus O3:K6, has resulted in the first documented pandemic spread of V. parahaemolyticus. We used microarray analyses to explore the presence of known virulence factors and genetic markers thought to be specific for V. parahaemolyticus O3:K6 and its clonal derivatives. Analyses of 48 human clinical isolates collected between 1997 and 2005 revealed that the V. parahaemolyticus chromosome 2 type III secretion system is not specifically associated with pandemic strains and can be found in tdh-negative (i.e., Kanagawa-negative) clinical isolates. These results highlight the genetic dynamism of V. parahaemolyticus and aid in refining the genetic definition of the pandemic group members.
* Corresponding author. Mailing address: Naval Research Laboratory, Center for Bio/Molecular Science & Engineering, 4555 Overlook Avenue SW, Bldg. 30, Code 6910, Washington, DC 20375. Phone: (202) 767-0394. Fax: (202) 404-8688. E-mail:
gvora{at}cbmse.nrl.navy.mil
Published ahead of print on 14 February 2007.
Journal of Clinical Microbiology, April 2007, p. 1133-1139, Vol. 45, No. 4
0095-1137/07/$08.00+0 doi:10.1128/JCM.00042-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hazen, T. H., Martinez, R. J., Chen, Y., Lafon, P. C., Garrett, N. M., Parsons, M. B., Bopp, C. A., Sullards, M. C., Sobecky, P. A.
(2009). Rapid Identification of Vibrio parahaemolyticus by Whole-Cell Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. Appl. Environ. Microbiol.
75: 6745-6756
[Abstract]
[Full Text]
-
Kodama, T., Hiyoshi, H., Gotoh, K., Akeda, Y., Matsuda, S., Park, K.-S., Cantarelli, V. V., Iida, T., Honda, T.
(2008). Identification of Two Translocon Proteins of Vibrio parahaemolyticus Type III Secretion System 2. Infect. Immun.
76: 4282-4289
[Abstract]
[Full Text]
-
Kam, K. M., Luey, C. K. Y., Parsons, M. B., Cooper, K. L. F., Nair, G. B., Alam, M., Islam, M. A., Cheung, D. T. L., Chu, Y. W., Ramamurthy, T., Pazhani, G. P., Bhattacharya, S. K., Watanabe, H., Terajima, J., Arakawa, E., Ratchtrachenchai, O.-A., Huttayananont, S., Ribot, E. M., Gerner-Smidt, P., Swaminathan, B., for the Vibrio parahaemolyticus PulseNet PFGE Prot,
(2008). Evaluation and Validation of a PulseNet Standardized Pulsed-Field Gel Electrophoresis Protocol for Subtyping Vibrio parahaemolyticus: an International Multicenter Collaborative Study. J. Clin. Microbiol.
46: 2766-2773
[Abstract]
[Full Text]
-
Casselli, T., Lynch, T., Southward, C. M., Jones, B. W., DeVinney, R.
(2008). Vibrio parahaemolyticus Inhibition of Rho Family GTPase Activation Requires a Functional Chromosome I Type III Secretion System. Infect. Immun.
76: 2202-2211
[Abstract]
[Full Text]
-
Izutsu, K., Kurokawa, K., Tashiro, K., Kuhara, S., Hayashi, T., Honda, T., Iida, T.
(2008). Comparative Genomic Analysis Using Microarray Demonstrates a Strong Correlation between the Presence of the 80-Kilobase Pathogenicity Island and Pathogenicity in Kanagawa Phenomenon-Positive Vibrio parahaemolyticus Strains. Infect. Immun.
76: 1016-1023
[Abstract]
[Full Text]